In primary prostate cancer, the immune microenvironment is characterized by suppressive myeloid cells and exhausted T cells, and the expression level of IL-7/IL-7R in this microenvironment is significantly higher than that in normal tissues. The gene discussed is IL7; the disease is prostate carcinoma.